Programs, populations, and payments verified via SAMHSA.
- Level of care
- Inpatient · IOP · MAT · Dual Dx · Telehealth
- Service settings
- Outpatient, Residential/24-hour residential, Intensive outpatient treatment, Outpatient methadone/buprenorphine or naltrexone treatment, Regular outpatient treatment, Long-term residential, Short-term residential
- Therapy approaches
- Anger management, Brief intervention, Cognitive behavioral therapy, Motivational interviewing, Relapse prevention, Substance use disorder counseling, Trauma-related counseling, Telemedicine/telehealth therapy
- Special populations
- Adolescents, Criminal justice (other than DUI/DWI)/Forensic clients, Clients with co-occurring mental and substance use disorders, Clients who have experienced trauma
- Medications used
- Buprenorphine with naloxone, Naltrexone (oral), Naltrexone (extended-release, injectable), Medication for mental disorders, Nicotine replacement, Non-nicotine smoking/tobacco cessation
- Recovery supports
- Housing services, Assistance with obtaining social services, Mentoring/peer support, Employment counseling or training
- Facility operation
- Private non-profit organization